Antibody-Based Immunotherapeutic Strategies for the Treatment of Hematological Malignancies

As the most common type of cancer in the world, hematological malignancies (HM) account for 10% of all annual cancer deaths and have attracted more attention. Conventional treatments, such as chemotherapy, radiotherapy, and hematopoietic stem cell transplantation (HSCT), could relieve patients suffe...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Yizhao, Liu, Zhuojun, Liu, Jia, Yan, Weiqi, Xia, Yuanshi, Yue, Shuhua, Yu, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519992/
https://www.ncbi.nlm.nih.gov/pubmed/33015169
http://dx.doi.org/10.1155/2020/4956946

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519992/
https://www.ncbi.nlm.nih.gov/pubmed/33015169
http://dx.doi.org/10.1155/2020/4956946

Ejemplares similares